Pharma & Healthcare

Global Disease Control and Prevention Vaccine Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Disease Control and Prevention Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Disease Control and Prevention Vaccine.
The Disease Control and Prevention Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Disease Control and Prevention Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Disease Control and Prevention Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo
Abbott Laboratories
Bharat Biotech International
Bavarian Nordic A/S
CSL Limited
Emergent BioSolutions Inc
Inovio Pharmaceuticals Inc
Johnson & Johnson
Mitsubishi Tanabe Pharma Corporation
Novavax Inc
Panacea Biotec Ltd
Takeda Pharmaceutical Company Limited
Segment by Type
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid
Segment by Application
Pediatric Vaccine
Adult Vaccine
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Disease Control and Prevention Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Live-Attenuated
1.2.3 Inactivated
1.2.4 Recombinant Sub Unit and Toxoid
1.3 Market by Application
1.3.1 Global Disease Control and Prevention Vaccine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Disease Control and Prevention Vaccine Market Perspective (2020-2031)
2.2 Global Disease Control and Prevention Vaccine Growth Trends by Region
2.2.1 Global Disease Control and Prevention Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Disease Control and Prevention Vaccine Historic Market Size by Region (2020-2025)
2.2.3 Disease Control and Prevention Vaccine Forecasted Market Size by Region (2026-2031)
2.3 Disease Control and Prevention Vaccine Market Dynamics
2.3.1 Disease Control and Prevention Vaccine Industry Trends
2.3.2 Disease Control and Prevention Vaccine Market Drivers
2.3.3 Disease Control and Prevention Vaccine Market Challenges
2.3.4 Disease Control and Prevention Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Disease Control and Prevention Vaccine Players by Revenue
3.1.1 Global Top Disease Control and Prevention Vaccine Players by Revenue (2020-2025)
3.1.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Players (2020-2025)
3.2 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Disease Control and Prevention Vaccine Revenue
3.4 Global Disease Control and Prevention Vaccine Market Concentration Ratio
3.4.1 Global Disease Control and Prevention Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Disease Control and Prevention Vaccine Revenue in 2024
3.5 Global Key Players of Disease Control and Prevention Vaccine Head office and Area Served
3.6 Global Key Players of Disease Control and Prevention Vaccine, Product and Application
3.7 Global Key Players of Disease Control and Prevention Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Disease Control and Prevention Vaccine Breakdown Data by Type
4.1 Global Disease Control and Prevention Vaccine Historic Market Size by Type (2020-2025)
4.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2026-2031)
5 Disease Control and Prevention Vaccine Breakdown Data by Application
5.1 Global Disease Control and Prevention Vaccine Historic Market Size by Application (2020-2025)
5.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Disease Control and Prevention Vaccine Market Size (2020-2031)
6.2 North America Disease Control and Prevention Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Disease Control and Prevention Vaccine Market Size by Country (2020-2025)
6.4 North America Disease Control and Prevention Vaccine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Disease Control and Prevention Vaccine Market Size (2020-2031)
7.2 Europe Disease Control and Prevention Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Disease Control and Prevention Vaccine Market Size by Country (2020-2025)
7.4 Europe Disease Control and Prevention Vaccine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Disease Control and Prevention Vaccine Market Size (2020-2031)
8.2 Asia-Pacific Disease Control and Prevention Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2020-2025)
8.4 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Disease Control and Prevention Vaccine Market Size (2020-2031)
9.2 Latin America Disease Control and Prevention Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Disease Control and Prevention Vaccine Market Size by Country (2020-2025)
9.4 Latin America Disease Control and Prevention Vaccine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Disease Control and Prevention Vaccine Market Size (2020-2031)
10.2 Middle East & Africa Disease Control and Prevention Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2020-2025)
10.4 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Disease Control and Prevention Vaccine Introduction
11.1.4 GSK Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.1.5 GSK Recent Development
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Introduction
11.2.4 Merck & Co., Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.2.5 Merck & Co., Inc Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Disease Control and Prevention Vaccine Introduction
11.3.4 Pfizer Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Disease Control and Prevention Vaccine Introduction
11.4.4 Sanofi Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Details
11.5.2 AstraZeneca PLC Business Overview
11.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Introduction
11.5.4 AstraZeneca PLC Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.5.5 AstraZeneca PLC Recent Development
11.6 Sinovac Biotech Ltd
11.6.1 Sinovac Biotech Ltd Company Details
11.6.2 Sinovac Biotech Ltd Business Overview
11.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Introduction
11.6.4 Sinovac Biotech Ltd Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.6.5 Sinovac Biotech Ltd Recent Development
11.7 Astellas Pharma Inc
11.7.1 Astellas Pharma Inc Company Details
11.7.2 Astellas Pharma Inc Business Overview
11.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Introduction
11.7.4 Astellas Pharma Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.7.5 Astellas Pharma Inc Recent Development
11.8 Serum Institute of India Pvt. Ltd
11.8.1 Serum Institute of India Pvt. Ltd Company Details
11.8.2 Serum Institute of India Pvt. Ltd Business Overview
11.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Introduction
11.8.4 Serum Institute of India Pvt. Ltd Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.8.5 Serum Institute of India Pvt. Ltd Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Introduction
11.9.4 Daiichi Sankyo Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.9.5 Daiichi Sankyo Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Disease Control and Prevention Vaccine Introduction
11.10.4 Abbott Laboratories Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.10.5 Abbott Laboratories Recent Development
11.11 Bharat Biotech International
11.11.1 Bharat Biotech International Company Details
11.11.2 Bharat Biotech International Business Overview
11.11.3 Bharat Biotech International Disease Control and Prevention Vaccine Introduction
11.11.4 Bharat Biotech International Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.11.5 Bharat Biotech International Recent Development
11.12 Bavarian Nordic A/S
11.12.1 Bavarian Nordic A/S Company Details
11.12.2 Bavarian Nordic A/S Business Overview
11.12.3 Bavarian Nordic A/S Disease Control and Prevention Vaccine Introduction
11.12.4 Bavarian Nordic A/S Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.12.5 Bavarian Nordic A/S Recent Development
11.13 CSL Limited
11.13.1 CSL Limited Company Details
11.13.2 CSL Limited Business Overview
11.13.3 CSL Limited Disease Control and Prevention Vaccine Introduction
11.13.4 CSL Limited Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.13.5 CSL Limited Recent Development
11.14 Emergent BioSolutions Inc
11.14.1 Emergent BioSolutions Inc Company Details
11.14.2 Emergent BioSolutions Inc Business Overview
11.14.3 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Introduction
11.14.4 Emergent BioSolutions Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.14.5 Emergent BioSolutions Inc Recent Development
11.15 Inovio Pharmaceuticals Inc
11.15.1 Inovio Pharmaceuticals Inc Company Details
11.15.2 Inovio Pharmaceuticals Inc Business Overview
11.15.3 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Introduction
11.15.4 Inovio Pharmaceuticals Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.15.5 Inovio Pharmaceuticals Inc Recent Development
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Company Details
11.16.2 Johnson & Johnson Business Overview
11.16.3 Johnson & Johnson Disease Control and Prevention Vaccine Introduction
11.16.4 Johnson & Johnson Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.16.5 Johnson & Johnson Recent Development
11.17 Mitsubishi Tanabe Pharma Corporation
11.17.1 Mitsubishi Tanabe Pharma Corporation Company Details
11.17.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.17.3 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Introduction
11.17.4 Mitsubishi Tanabe Pharma Corporation Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.17.5 Mitsubishi Tanabe Pharma Corporation Recent Development
11.18 Novavax Inc
11.18.1 Novavax Inc Company Details
11.18.2 Novavax Inc Business Overview
11.18.3 Novavax Inc Disease Control and Prevention Vaccine Introduction
11.18.4 Novavax Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.18.5 Novavax Inc Recent Development
11.19 Panacea Biotec Ltd
11.19.1 Panacea Biotec Ltd Company Details
11.19.2 Panacea Biotec Ltd Business Overview
11.19.3 Panacea Biotec Ltd Disease Control and Prevention Vaccine Introduction
11.19.4 Panacea Biotec Ltd Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.19.5 Panacea Biotec Ltd Recent Development
11.20 Takeda Pharmaceutical Company Limited
11.20.1 Takeda Pharmaceutical Company Limited Company Details
11.20.2 Takeda Pharmaceutical Company Limited Business Overview
11.20.3 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Introduction
11.20.4 Takeda Pharmaceutical Company Limited Revenue in Disease Control and Prevention Vaccine Business (2020-2025)
11.20.5 Takeda Pharmaceutical Company Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Live-Attenuated
Table 3. Key Players of Inactivated
Table 4. Key Players of Recombinant Sub Unit and Toxoid
Table 5. Global Disease Control and Prevention Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Disease Control and Prevention Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Disease Control and Prevention Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Disease Control and Prevention Vaccine Market Share by Region (2020-2025)
Table 9. Global Disease Control and Prevention Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Disease Control and Prevention Vaccine Market Share by Region (2026-2031)
Table 11. Disease Control and Prevention Vaccine Market Trends
Table 12. Disease Control and Prevention Vaccine Market Drivers
Table 13. Disease Control and Prevention Vaccine Market Challenges
Table 14. Disease Control and Prevention Vaccine Market Restraints
Table 15. Global Disease Control and Prevention Vaccine Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Disease Control and Prevention Vaccine Market Share by Players (2020-2025)
Table 17. Global Top Disease Control and Prevention Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2024)
Table 18. Ranking of Global Top Disease Control and Prevention Vaccine Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Disease Control and Prevention Vaccine Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Disease Control and Prevention Vaccine, Headquarters and Area Served
Table 21. Global Key Players of Disease Control and Prevention Vaccine, Product and Application
Table 22. Global Key Players of Disease Control and Prevention Vaccine, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Disease Control and Prevention Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2020-2025)
Table 26. Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2026-2031)
Table 28. Global Disease Control and Prevention Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2020-2025)
Table 30. Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2026-2031)
Table 32. North America Disease Control and Prevention Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Disease Control and Prevention Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Disease Control and Prevention Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Disease Control and Prevention Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Disease Control and Prevention Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Disease Control and Prevention Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Disease Control and Prevention Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Disease Control and Prevention Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Disease Control and Prevention Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Disease Control and Prevention Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 47. GSK Company Details
Table 48. GSK Business Overview
Table 49. GSK Disease Control and Prevention Vaccine Product
Table 50. GSK Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 51. GSK Recent Development
Table 52. Merck & Co., Inc Company Details
Table 53. Merck & Co., Inc Business Overview
Table 54. Merck & Co., Inc Disease Control and Prevention Vaccine Product
Table 55. Merck & Co., Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 56. Merck & Co., Inc Recent Development
Table 57. Pfizer Company Details
Table 58. Pfizer Business Overview
Table 59. Pfizer Disease Control and Prevention Vaccine Product
Table 60. Pfizer Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Disease Control and Prevention Vaccine Product
Table 65. Sanofi Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. AstraZeneca PLC Company Details
Table 68. AstraZeneca PLC Business Overview
Table 69. AstraZeneca PLC Disease Control and Prevention Vaccine Product
Table 70. AstraZeneca PLC Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 71. AstraZeneca PLC Recent Development
Table 72. Sinovac Biotech Ltd Company Details
Table 73. Sinovac Biotech Ltd Business Overview
Table 74. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product
Table 75. Sinovac Biotech Ltd Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 76. Sinovac Biotech Ltd Recent Development
Table 77. Astellas Pharma Inc Company Details
Table 78. Astellas Pharma Inc Business Overview
Table 79. Astellas Pharma Inc Disease Control and Prevention Vaccine Product
Table 80. Astellas Pharma Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 81. Astellas Pharma Inc Recent Development
Table 82. Serum Institute of India Pvt. Ltd Company Details
Table 83. Serum Institute of India Pvt. Ltd Business Overview
Table 84. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product
Table 85. Serum Institute of India Pvt. Ltd Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 86. Serum Institute of India Pvt. Ltd Recent Development
Table 87. Daiichi Sankyo Company Details
Table 88. Daiichi Sankyo Business Overview
Table 89. Daiichi Sankyo Disease Control and Prevention Vaccine Product
Table 90. Daiichi Sankyo Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 91. Daiichi Sankyo Recent Development
Table 92. Abbott Laboratories Company Details
Table 93. Abbott Laboratories Business Overview
Table 94. Abbott Laboratories Disease Control and Prevention Vaccine Product
Table 95. Abbott Laboratories Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 96. Abbott Laboratories Recent Development
Table 97. Bharat Biotech International Company Details
Table 98. Bharat Biotech International Business Overview
Table 99. Bharat Biotech International Disease Control and Prevention Vaccine Product
Table 100. Bharat Biotech International Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 101. Bharat Biotech International Recent Development
Table 102. Bavarian Nordic A/S Company Details
Table 103. Bavarian Nordic A/S Business Overview
Table 104. Bavarian Nordic A/S Disease Control and Prevention Vaccine Product
Table 105. Bavarian Nordic A/S Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 106. Bavarian Nordic A/S Recent Development
Table 107. CSL Limited Company Details
Table 108. CSL Limited Business Overview
Table 109. CSL Limited Disease Control and Prevention Vaccine Product
Table 110. CSL Limited Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 111. CSL Limited Recent Development
Table 112. Emergent BioSolutions Inc Company Details
Table 113. Emergent BioSolutions Inc Business Overview
Table 114. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product
Table 115. Emergent BioSolutions Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 116. Emergent BioSolutions Inc Recent Development
Table 117. Inovio Pharmaceuticals Inc Company Details
Table 118. Inovio Pharmaceuticals Inc Business Overview
Table 119. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product
Table 120. Inovio Pharmaceuticals Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 121. Inovio Pharmaceuticals Inc Recent Development
Table 122. Johnson & Johnson Company Details
Table 123. Johnson & Johnson Business Overview
Table 124. Johnson & Johnson Disease Control and Prevention Vaccine Product
Table 125. Johnson & Johnson Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 126. Johnson & Johnson Recent Development
Table 127. Mitsubishi Tanabe Pharma Corporation Company Details
Table 128. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 129. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product
Table 130. Mitsubishi Tanabe Pharma Corporation Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 131. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 132. Novavax Inc Company Details
Table 133. Novavax Inc Business Overview
Table 134. Novavax Inc Disease Control and Prevention Vaccine Product
Table 135. Novavax Inc Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 136. Novavax Inc Recent Development
Table 137. Panacea Biotec Ltd Company Details
Table 138. Panacea Biotec Ltd Business Overview
Table 139. Panacea Biotec Ltd Disease Control and Prevention Vaccine Product
Table 140. Panacea Biotec Ltd Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 141. Panacea Biotec Ltd Recent Development
Table 142. Takeda Pharmaceutical Company Limited Company Details
Table 143. Takeda Pharmaceutical Company Limited Business Overview
Table 144. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product
Table 145. Takeda Pharmaceutical Company Limited Revenue in Disease Control and Prevention Vaccine Business (2020-2025) & (US$ Million)
Table 146. Takeda Pharmaceutical Company Limited Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report


List of Figures
Figure 1. Disease Control and Prevention Vaccine Picture
Figure 2. Global Disease Control and Prevention Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Disease Control and Prevention Vaccine Market Share by Type: 2024 VS 2031
Figure 4. Live-Attenuated Features
Figure 5. Inactivated Features
Figure 6. Recombinant Sub Unit and Toxoid Features
Figure 7. Global Disease Control and Prevention Vaccine Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Disease Control and Prevention Vaccine Market Share by Application: 2024 VS 2031
Figure 9. Pediatric Vaccine Case Studies
Figure 10. Adult Vaccine Case Studies
Figure 11. Disease Control and Prevention Vaccine Report Years Considered
Figure 12. Global Disease Control and Prevention Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Disease Control and Prevention Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Disease Control and Prevention Vaccine Market Share by Region: 2024 VS 2031
Figure 15. Global Disease Control and Prevention Vaccine Market Share by Players in 2024
Figure 16. Global Top Disease Control and Prevention Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Disease Control and Prevention Vaccine Revenue in 2024
Figure 18. North America Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Disease Control and Prevention Vaccine Market Share by Country (2020-2031)
Figure 20. United States Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Disease Control and Prevention Vaccine Market Share by Country (2020-2031)
Figure 24. Germany Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Region (2020-2031)
Figure 32. China Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Disease Control and Prevention Vaccine Market Share by Country (2020-2031)
Figure 40. Mexico Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Disease Control and Prevention Vaccine Market Share by Country (2020-2031)
Figure 44. Turkey Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Disease Control and Prevention Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 48. Merck & Co., Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 51. AstraZeneca PLC Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 52. Sinovac Biotech Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 53. Astellas Pharma Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 54. Serum Institute of India Pvt. Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 55. Daiichi Sankyo Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 56. Abbott Laboratories Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 57. Bharat Biotech International Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 58. Bavarian Nordic A/S Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 59. CSL Limited Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 60. Emergent BioSolutions Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 61. Inovio Pharmaceuticals Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 62. Johnson & Johnson Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 63. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 64. Novavax Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 65. Panacea Biotec Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 66. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies